Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 298 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Long-Term Responders with No Evidence of Disease Have Better Survival to... May 16, 2022 EMA Recommends Extension of Indications for Serplulimab April 22, 2026 Grandma Saves Her Money To Put Up A Billboard For Everyone... June 14, 2019 EMA Recommends Granting a Marketing Authorisation for Celdoxome Pegylated Liposomal September 1, 2022 Load more HOT NEWS Researchers Create Modified Antibodies to Target RAS and p53 in Cancer Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent... How to Provide Support as a Long-Distance Cancer Caregiver “White Bagging” Harmful to Patients, Requires Them to Use Insurance-Approved Formulary...
